Valuation Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2025-07-18			5-day change	1st Jan Change
55.30 ^CNY	-0.09%		+3.58%	+10.95%

06-17	Xingqi Pharmaceutical Begins Phase Three Trial for Anesthetic Gel	MT
05-30	Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Capitalization ¹	5,869	7,612	11,263	11,076	22,715	12,229
Change	-	29.71%	47.96%	-1.66%	105.08%	-46.16%
Enterprise Value (EV) ¹	5,909	7,655	10,688	10,575	22,314	12,074
Change	-	29.55%	39.62%	-1.06%	111.01%	-45.89%
P/E ratio	163x	88.2x	57.5x	51.9x	94.5x	36.2x
PBR	9.6x	11.5x	8.96x	7.14x	13.4x	7.68x
PEG	-	1x	0x	37.92x	7.8x	0.9x
Capitalization / Revenue	10.8x	11.1x	11x	8.86x	15.5x	6.29x
EV / Revenue	10.9x	11.1x	10.4x	8.46x	15.2x	6.21x
EV / EBITDA	76x	50.9x	36x	35.8x	66.1x	24.2x
EV / EBIT	158x	72.6x	44.5x	45.7x	85.8x	29.6x
EV / FCF	603x	-459x	84x	-79.4x	-1,071x	58.1x
FCF Yield	0.17%	-0.22%	1.19%	-1.26%	-0.09%	1.72%
Dividend per Share ²	0.0456	0.0911	0.2369	0.5466	1.888	1.071
Rate of return	0.17%	0.26%	0.48%	1.2%	2.03%	2.15%
EPS ²	0.164	0.3936	0.8664	0.8783	0.9847	1.379
Distribution rate	27.8%	23.1%	27.3%	62.2%	192%	77.7%
Net sales ¹	542.4	688.7	1,028	1,250	1,468	1,943
EBITDA ¹	77.72	150.2	296.8	295.5	337.8	499.8
EBIT ¹	37.49	105.4	240.3	231.2	259.9	408.4
Net income ¹	35.89	87.98	194.7	211.7	240	338.1
Net Debt ¹	40.04	42.78	-575.1	-501.6	-401.3	-154.8
Reference price ²	26.73	34.70	49.85	45.58	93.02	49.84
Nbr of stocks (in thousands)	219,520	219,343	225,921	242,995	244,195	245,349
Announcement Date	4/19/20	4/19/21	4/19/22	4/19/23	4/18/24	4/21/25

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	1.89B
MERCK KGAA	15.52x	2.51x	8.85x	2.11%	56.04B
KYOWA KIRIN CO., LTD.	23.75x	2.28x	10.44x	2.39%	8.9B
YUHAN CORPORATION	85x	4.32x	53.1x	0.37%	7.1B
HALOZYME THERAPEUTICS, INC.	11.9x	5.9x	8.94x	-	6.96B
SK BIOPHARMACEUTICALS CO., LTD.	60.15x	10.99x	43.9x	-.--%	5.81B
BETTA PHARMACEUTICALS CO., LTD.	37.25x	7.64x	19.19x	0.57%	3.69B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	12.14x	-	-	2.05%	2.04B
SUPERNUS PHARMACEUTICALS, INC.	281.22x	-	-	-	2.03B
Average	65.87x	5.61x	24.07x	1.25%	10.5B
Weighted average by Cap.	30.78x	3.67x	15.30x	1.77%